Advertisement

New ACR EULAR Guidelines for Systemic Sclerosis Classification

  • Sindhu R. Johnson
Scleroderma (J Varga, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Scleroderma

Abstract

The American College of Rheumatology and European League Against Rheumatism classification criteria for systemic sclerosis are a significant advancement in the field. This article describes the innovative, rigorous, criteria development strategy that was used. The new criteria build upon previous criteria by incorporating important elements (proximal scleroderma, sclerodactyly, digital pits, pulmonary fibrosis, Raynaud’s phenomenon, and scleroderma specific autoantibodies). The new criteria add emphasis to the vasculopathic manifestations, and include the early manifestation of puffy fingers. Together, these enhancements have resulted in a shift in the conceptual framework of the disease for the next generation. The new criteria have improved sensitivity and specifically, particularly among cases with early disease, mild disease, or limited disease. The ability to classify more cases, at an earlier stage, may confer the opportunity to intervene and prevent disease progression. Undoubtedly, this will lead to a paradigm shift in the conduct of clinical trials in systemic sclerosis.

Keywords

Systemic sclerosis Scleroderma Classification criteria Classification Misclassification Clinical epidemiology Cohort Delphi Nominal group technique Bayesian Multicriteria decision analysis Conjoint analysis Forced choice 1000Minds Mixed connective tissue disease 

Notes

Acknowledgments

Sindhu Johnson has been awarded a Canadian Institutes of Health Research Clinician Scientist Award and is supported by the Freda Fejer Fund and the Norton-Evans Fund for Scleroderma Research.

Compliance with Ethics Guidelines

Conflict of Interest

Sindhu Johnson declares grants from American College of Rheumatology and from the European League Against Rheumatism, during the writing of this paper. She declares that she is Co-chair of the American College of Rheumatology Classification and Response Criteria subcommittee.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.••
    Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65(8):1953–62. This paper highlights the importance of vascular manifestations of systemic sclerosis. CrossRefPubMedGoogle Scholar
  2. 2.
    Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23(5):581–90.Google Scholar
  3. 3.
    Preliminary criteria for the classification of systemic sclerosis (scleroderma). BullRheumDis. 1981;31(1):1–6.Google Scholar
  4. 4.
    Nadashkevich O, Davis P, Fritzler MJ. A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit. 2004;10(11):CR615–21.PubMedGoogle Scholar
  5. 5.
    Nadashkevich O, Davis P, Fritzler MJ. Revising the classification criteria for systemic sclerosis. Arthritis Rheum. 2006;55(6):992–3.CrossRefPubMedGoogle Scholar
  6. 6.
    LeRoy EC, Medsger Jr TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573–6.PubMedGoogle Scholar
  7. 7.
    Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70(3):476–81.CrossRefPubMedGoogle Scholar
  8. 8.
    Johnson SR, Goek ON, Singh-Grewal D, Vlad SC, Feldman BM, Felson DT, et al. Classification criteria in rheumatic diseases: a review of methodologic properties. Arthritis Rheum. 2007;57(7):1119–33.CrossRefPubMedGoogle Scholar
  9. 9.
    Pope JE. Systemic sclerosis classification: a rose by any other name would smell as sweet? J Rheumatol. 2015;42(1):11–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001;44(3):735–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Wigley FM. When is scleroderma really scleroderma? J Rheumatol. 2001;28(7):1471–3.PubMedGoogle Scholar
  12. 12.
    Wollheim FA. Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford). 2005;44(10):1212–6.CrossRefGoogle Scholar
  13. 13.
    LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.PubMedGoogle Scholar
  14. 14.
    Johnson SR, Feldman BM, Hawker GA. Classification criteria for systemic sclerosis subsets. J Rheumatol. 2007;34(9):1855–63.PubMedGoogle Scholar
  15. 15.
    Masi AT, Medsger Jr TA. Progress in the evolution of systemic sclerosis classification criteria and recommendation for additional comparative specificity studies. J Rheumatol. 2015;42(1):8–10.CrossRefPubMedGoogle Scholar
  16. 16.
    Barnett AJ, Coventry DA. Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust. 1969;1(19):992–1001.PubMedGoogle Scholar
  17. 17.
    Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002;81(2):139–53.CrossRefGoogle Scholar
  18. 18.
    Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol. 1986;13(5):911–6.PubMedGoogle Scholar
  19. 19.
    Goetz R, Berne M. The pathophysiology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in the viscere. Clin Proc. 1945;4:337–92.Google Scholar
  20. 20.
    Holzmann H, Sollberg S, Altmeyer P. Classification of progressive systemic scleroderma. Hautarzt. 1987;38(5):253–7.PubMedGoogle Scholar
  21. 21.
    Maricq HR, Valter I. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol. 2004;22(3 Suppl 33):S5–13.PubMedGoogle Scholar
  22. 22.
    Masi AT. Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol. 1988;15(6):894–8.PubMedGoogle Scholar
  23. 23.
    Rodnan GP, Jablonska S, Medsger TA. Classification and nomenclature of progressive systemic sclerosis. Clin Rheum Dis. 1979;5(1):5–13.Google Scholar
  24. 24.
    Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore). 2002;81(2):154–67.CrossRefGoogle Scholar
  25. 25.
    Tuffanelli DL, Winkelmann RK. Diffuse systemic scleroderma. A comparison with acrosclerosis. Ann Intern Med. 1962;57:198–203.CrossRefPubMedGoogle Scholar
  26. 26.
    Winterbauer RH. Multiple telengiectasia, Raynaud’s phenomenon, sclerodactyly, and subcutaneous calcinosis: a syndrome mimicking hereditary hemorrhagic telengiectasia. Bull Johns Hopkins Hosp. 1964;114:361–83.PubMedGoogle Scholar
  27. 27.
    Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford). 2011;50(2):317–23.CrossRefGoogle Scholar
  28. 28.
    Felson DT, Anderson JJ. Methodological and statistical approaches to criteria development in rheumatic diseases. Baillieres Clin Rheumatol. 1995;9(2):253–66.CrossRefPubMedGoogle Scholar
  29. 29.
    Singh JA, Solomon DH, Dougados M, Felson D, Hawker G, Katz P, et al. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum. 2006;55(3):348–52.CrossRefPubMedGoogle Scholar
  30. 30.
    Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheum Dis. 2004;63(9):1172–6.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Dougados M, Gossec L. Classification criteria for rheumatic diseases: why and how? Arthritis Rheum. 2007;57(7):1112–5.CrossRefPubMedGoogle Scholar
  32. 32.••
    van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47. This paper outlines the new American College of Rheumatology European League Against Rheumatism classification criteria for systemic sclerosis. CrossRefPubMedCentralPubMedGoogle Scholar
  33. 33.••
    van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Ann Rheum Dis. 2013;72(11):1747–55. This paper outlines the new American College of Rheumatology European League Against Rheumatism classification criteria for systemic sclerosis. CrossRefPubMedGoogle Scholar
  34. 34.•
    Fransen J, Johnson SR, van den Hoogen F, Baron M, Allanore Y, Carreira PE, et al. Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise. Arthritis Care Res. 2012;64(3):351–7. This paper describes the use of Delphi methods and nominal group technique for classification criteria development. CrossRefGoogle Scholar
  35. 35.
    Coulter C, Baron M, Pope JE. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases. Clin Exp Rheumatol. 2013;31(2 Suppl 76):24–30.PubMedGoogle Scholar
  36. 36.•
    Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger Jr TA, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res. 2012;64(3):358–67. This paper describes validation of candidate criteria in cases and controls from multiple international cohorts. CrossRefGoogle Scholar
  37. 37.•
    Johnson SR, Naden RP, Fransen J, van den Hoogen F, Pope JE, Baron M, et al. Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria. J Clin Epidemiol. 2014;67(6):706–14. This paper describes the use of multicriteria decision analysis (conjoint analysis) for classification criteria development. CrossRefPubMedGoogle Scholar
  38. 38.
    Alhajeri H, Hudson M, Fritzler M, Pope J, Tatibouet S, Markland J, et al. The 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis Out-Perform the 1980 Criteria. Data from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken). 2015. In press.Google Scholar
  39. 39.
    Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol. 2015;42(1):60–3.CrossRefPubMedGoogle Scholar
  40. 40.
    Aggarwal R, Ringold S, Khanna D, Neogi T, Johnson SR, Miller A, et al. Are diagnostic criteria different than classification criteria? Arthritis Care Res (Hoboken). 2015; in press.Google Scholar
  41. 41.
    Johnson SR, Tomlinson GA, Hawker GA, Granton JT, Feldman BM. Methods to elicit beliefs for Bayesian priors: a systematic review. J Clin Epidemiol. 2010;63(4):355–69.CrossRefPubMedGoogle Scholar
  42. 42.
    Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino Jr AV, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol. 2006;33(5):1004–13.PubMedGoogle Scholar
  43. 43.
    Johnson SR, Laxer RM. Classification in systemic sclerosis. J Rheumatol. 2006;33(5):840–1.PubMedGoogle Scholar
  44. 44.
    Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirjak L, et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis. 2014;73(12):2087–93.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Toronto Scleroderma Program, Mount Sinai Hospital, Toronto Western Hospital, Division of Rheumatology, Department of MedicineUniversity of TorontoTorontoCanada
  2. 2.Institute of Health Policy, Management and EvaluationUniversity of TorontoTorontoCanada

Personalised recommendations